Robert David Steele, Simon Parkes, and Charlie Ward.
By Simon Parkes
Low-Dose Naltrexone: A Potential ‘Wonder Drug’ Held Back by Costly Trials
October 3, 2024
No Comments
Read More »
Robert David Steele, Simon Parkes, and Charlie Ward.
By Simon Parkes
Some research supports the use of anti-inflammatory low-dose naltrexone for chronic pain and autoimmune conditions. Low-dose naltrexone (LDN) is generating buzz as a potential treatment
From Senator Gerard Rennick It’s been a very busy few weeks since my last update working on a number of tasks as outlined below. Party
Updated3 mins Ago The Israeli military says that in total Hezbollah launched 240 rockets over the border from southern Lebanon on Wednesday. | Published Oct
Australian National Review is Australia’s first real free and independent press, one with no editorial control by the elite, but a publication that can generate critical thinkers and critical debate and hold those spreading mistruths and deliberate propaganda in mainstream media to account.
News with a difference that will be educational, compelling and create a platform for political and social change in this country and address the real issues facing this country and the world.
